[1]
M. Bara, J. Starownik, J. Szydło, P. Gryszkiewicz, and J. Nieznański, “Dapagliflozin - new solution in chronic kidney disease treatment”, Prosp. Pharm. Sc., vol. 22, no. 2, pp. 59–64, Jun. 2024.